Biocoat Takes Bold Steps in Coating Market with Hydak UV Technology

The Horsham, PA-based company said its Hydak UV coating is now being used on two FDA-cleared devices.

Omar Ford

April 17, 2023

2 Min Read
Image Credit: Kumer via iStock / Getty Images

Biocoat Inc. is making some substantial noise in the coating market. The Horsham, PA-based company has announced the milestone of having its Hydak UV coating used on two FDA-cleared medical devices.

The first interventional device using HYDAK UV that received the 510(k) clearance is a neurovascular thrombus retriever catheter. The second device is an interventional use catheter designed to remove thrombus from the peripheral vasculature. 

"The design and engineering teams from both organizations have collaborated closely to deliver the best coating design to maximize performance on their unique device,” Jim Moran, Biocoat’s president and CEO told MD+DI. “In addition, one of the companies will be using Biocoat's in-house cGMP coating services to apply Hydak UV to their finished medical device."

The Hydak UV coating has had rapid success. The technology, which supports catheter designs, was launched in 2020 and received a patent in 2022. According to the company’s website, the Hydak UV coating in a bi-laminar platform that offers strong results in lubricity, durability, and particulates.

The firm went on to say that UV cure coatings are used on many medical devices that require a hydrophilic coating, particularly in the cardiovascular market.

Biocoat has been on an upward trajectory over the past few months. The company kicked off November of 2022 announcing a strategic investment from GTCR, a private equity firm.  The investment helped Biocoat foster growth in the biomaterial coatings market. The financing also opened opportunities for global growth, enhanced product offerings, and manufacturing facility expansion, according to the company’s website.

The firm also announced in 2022 that it was expanding into the design, development, and delivery of hydrophilic dip coating equipment. Biocoat said the newly expanded equipment line is called Emerse and offers companies that require an in-house dip coating system to coat their medical devices and complete the production process.

There is going to be significant demand on coating technologies, according to a report from Roots Analysis in January. The  Medical Device Coatings and Surface Modification Technologies Market report points out that burgeoning development of more sophisticated medical devices is also encouraging the production of more innovative medical device coatings.


About the Author(s)

Omar Ford

Omar Ford is MD+DI's Editor-in-Chief. You can reach him at [email protected].


Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like